These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 16040213

  • 1. Controlled release of levonorgestrel from biodegradable poly(D,L-lactide-co-glycolide) microspheres: in vitro and in vivo studies.
    Wang SH, Zhang LC, Lin F, Sa XY, Zuo JB, Shao QX, Chen GS, Zeng S.
    Int J Pharm; 2005 Sep 14; 301(1-2):217-25. PubMed ID: 16040213
    [Abstract] [Full Text] [Related]

  • 2. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study.
    Dhanaraju MD, Rajkannan R, Selvaraj D, Jayakumar R, Vamsadhara C.
    Contraception; 2006 Aug 14; 74(2):148-56. PubMed ID: 16860053
    [Abstract] [Full Text] [Related]

  • 3. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S, Shi Y, Li L, Xu J, Schaper A, Kissel T.
    Eur J Pharm Biopharm; 2008 Feb 14; 68(2):214-23. PubMed ID: 17651954
    [Abstract] [Full Text] [Related]

  • 4. PLGA/mesoporous silica hybrid structure for controlled drug release.
    Xue JM, Shi M.
    J Control Release; 2004 Aug 11; 98(2):209-17. PubMed ID: 15262413
    [Abstract] [Full Text] [Related]

  • 5. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
    Hazekawa M, Sakai Y, Yoshida M, Haraguchi T, Morisaki T, Uchida T.
    J Pharm Pharmacol; 2011 Mar 11; 63(3):362-8. PubMed ID: 21749383
    [Abstract] [Full Text] [Related]

  • 6. [Pharmacokinetics of levonorgestrel after a single dose of biodegradable microspheres containing levonorgestrel in rats].
    Zhang LC, Sang GW, Shao QX.
    Yao Xue Xue Bao; 1994 Mar 11; 29(8):561-5. PubMed ID: 7985513
    [Abstract] [Full Text] [Related]

  • 7. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
    Janoria KG, Mitra AK.
    Int J Pharm; 2007 Jun 29; 338(1-2):133-41. PubMed ID: 17363204
    [Abstract] [Full Text] [Related]

  • 8. Optimisation of aciclovir poly(D,L-lactide-co-glycolide) microspheres for intravitreal administration using a factorial design study.
    Martínez-Sancho C, Herrero-Vanrell R, Negro S.
    Int J Pharm; 2004 Apr 01; 273(1-2):45-56. PubMed ID: 15010129
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic effect of in vivo sustained estradiol release from poly (lactide-co-glycolide) microspheres on bone mineral density of osteoporosis rats.
    Otsuka M, Uenodan H, Matsuda Y, Mogi T, Ohshima H, Makino K.
    Biomed Mater Eng; 2002 Apr 01; 12(2):157-67. PubMed ID: 12122239
    [Abstract] [Full Text] [Related]

  • 10. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
    Khan A, Sommer W, Fuxe K, Akhtar S.
    J Drug Target; 2000 Apr 01; 8(5):319-34. PubMed ID: 11328659
    [Abstract] [Full Text] [Related]

  • 11. Controlled release of huperzine A from biodegradable microspheres: In vitro and in vivo studies.
    Gao P, Xu H, Ding P, Gao Q, Sun J, Chen D.
    Int J Pharm; 2007 Feb 07; 330(1-2):1-5. PubMed ID: 16987624
    [Abstract] [Full Text] [Related]

  • 12. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS, Ramakrishna S, Saini TR, Diwan PV.
    Pharmazie; 2006 Jul 07; 61(7):613-7. PubMed ID: 16889069
    [Abstract] [Full Text] [Related]

  • 13. Poly (D, L-lactide-co-glycolide)/DNA microspheres to facilitate prolonged transgene expression in airway epithelium in vitro, ex vivo and in vivo.
    Stern M, Ulrich K, Geddes DM, Alton EW.
    Gene Ther; 2003 Aug 07; 10(16):1282-8. PubMed ID: 12883524
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
    Su ZX, Shi YN, Teng LS, Li X, Wang LX, Meng QF, Teng LR, Li YX.
    Pharm Dev Technol; 2011 Aug 07; 16(4):377-84. PubMed ID: 20370594
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres.
    Sun F, Sui C, Teng L, Liu X, Teng L, Meng Q, Li Y.
    Int J Pharm; 2010 Sep 15; 397(1-2):44-9. PubMed ID: 20600717
    [Abstract] [Full Text] [Related]

  • 19. Incorporation and release of vancomycin from poly(D,L-lactide-co-glycolide) microspheres.
    Atkins TW, Peacock SJ, Yates DJ.
    J Microencapsul; 1998 Sep 15; 15(1):31-44. PubMed ID: 9463805
    [Abstract] [Full Text] [Related]

  • 20. Gamma irradiated micro system for long-term parenteral contraception: An alternative to synthetic polymers.
    Puthli S, Vavia P.
    Eur J Pharm Sci; 2008 Nov 15; 35(4):307-17. PubMed ID: 18760352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.